Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis
BACKGROUND: The increasing prevalence of nonalcoholic fatty liver disease has led to a strong demand for an optimal therapeutic approach. At present, guidelines recommend lifestyle changes, but it has become apparent that pharmacotherapy will be required in patients with advanced disease to prevent...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Text |
| Taal: | Engels |
| Gepubliceerd in: |
S. Karger GmbH
2020
|
| Onderwerpen: | |
| Online toegang: | https://pmc.ncbi.nlm.nih.gov/articles/PMC7672521/ https://pubmed.ncbi.nlm.nih.gov/33251276 http://dx.doi.org/10.1159/000507231 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|